Skip to main content
. 2024 Feb 6;69:102471. doi: 10.1016/j.eclinm.2024.102471

Fig. 2.

Fig. 2

Local control rate (A), progression-free survival (B) and overall survival (C) in enrolled patients. Median overall survival and progression-free survival was not reached. Lower quartiles of progression-free survival and overall survival was 9.47 (95% CI 7.50–18.0) months and 25.0 (95% CI 12.7–NR) months, respectively.